{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:20:54Z","timestamp":1760833254450,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY19H090023"],"award-info":[{"award-number":["LY19H090023"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["188020-193810101\/ 089"],"award-info":[{"award-number":["188020-193810101\/ 089"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.nmd.2021.02.009","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T09:38:48Z","timestamp":1613381928000},"page":"442-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and genetic characteristics of Chinese patients with reducing body myopathy"],"prefix":"10.1016","volume":"31","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Xia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Lin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong-Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.02.009_bib0001","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-1119(98)00302-3","article-title":"Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1)","volume":"216","author":"Lee","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.nmd.2021.02.009_bib0002","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nrm1499","article-title":"The LIM domain: from the cytoskeleton to the nucleus","volume":"5","author":"Kadrmas","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nmd.2021.02.009_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.1110","article-title":"Characterization of tissue-specific LIM domain protein (FHL1C) which is an alternatively spliced isoform of a human LIM-only protein (FHL1)","volume":"82","author":"Ng","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.nmd.2021.02.009_bib0004","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0378-1119(99)00251-6","article-title":"Characterization of a brain-specific nuclear LIM domain protein (FHL1B) which is an alternatively spliced variant of FHL1","volume":"237","author":"Lee","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.nmd.2021.02.009_bib0005","doi-asserted-by":"crossref","first-page":"27083","DOI":"10.1074\/jbc.274.38.27083","volume":"274","author":"Brown","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2021.02.009_bib0006","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1074\/jbc.M512552200","article-title":"Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly","volume":"281","author":"McGrath","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2021.02.009_bib0007","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajhg.2007.09.013","article-title":"X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1","volume":"82","author":"Quinzii","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.02.009_bib0008","first-page":"904","article-title":"Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy","volume":"118","author":"Schessl","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2021.02.009_bib0009","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/brain\/awn325","article-title":"Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1","volume":"132","author":"Schessl","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.02.009_bib0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/01.wnl.0000341311.84347.a0","article-title":"Novel FHL1 mutations in fatal and benign reducing body myopathy","volume":"72","author":"Shalaby","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.02.009_bib0011","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajhg.2007.09.004","article-title":"An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1","volume":"82","author":"Windpassinger","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.02.009_bib0012","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCGENETICS.115.001193","article-title":"Exome sequencing identified a splice site mutation in FHL1 that causes Uruguay syndrome, an X-linked disorder with skeletal muscle hypertrophy and premature cardiac death","volume":"9","author":"Xue","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.nmd.2021.02.009_bib0013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCGENETICS.113.000245","article-title":"Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene","volume":"6","author":"Hartmannova","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.nmd.2021.02.009_bib0014","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejmg.2013.03.001","article-title":"Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1","volume":"56","author":"Gossios","year":"2013","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.nmd.2021.02.009_bib0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajhg.2009.07.015","article-title":"Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy","volume":"85","author":"Gueneau","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.02.009_bib0016","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.22.8.829","article-title":"Reducing body myopathy","volume":"22","author":"Brooke","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.02.009_bib0017","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.nmd.2008.09.012","article-title":"Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1)","volume":"18","author":"Shalaby","year":"2008","journal-title":"Neuromuscul disord"},{"key":"10.1016\/j.nmd.2021.02.009_bib0018","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s10038-019-0627-z","article-title":"FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy","volume":"64","author":"Hu","year":"2019","journal-title":"J Hum Genet"},{"issue":"215","key":"10.1016\/j.nmd.2021.02.009_bib0019","first-page":"e15","article-title":"Mutation screening in Chinese patients with familial Alzheimer's disease by whole-exome sequencing","volume":"76","author":"Jiang","year":"2019","journal-title":"Neurobiol Aging"},{"issue":"216","key":"10.1016\/j.nmd.2021.02.009_bib0020","first-page":"e1","article-title":"Clinical features of Chinese patients with Gerstmann-Str\u00e4ussler-Scheinker identified by targeted next-generation sequencing","volume":"49","author":"Li","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nmd.2021.02.009_bib0021","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.4103\/0366-6999.211539","article-title":"A novel missense mutation in peripheral myelin protein-22 causes Charcot-Marie-Tooth disease","volume":"130","author":"Li","year":"2017","journal-title":"Chin Med J"},{"key":"10.1016\/j.nmd.2021.02.009_bib0022","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.nmd.2017.06.014","article-title":"Gluteus maximus hypertrophy: A diagnostic clue in four and a half LIM domain 1-mutated reducing body myopathy","volume":"27","author":"Jokela","year":"2017","journal-title":"Neuromuscul disord"},{"key":"10.1016\/j.nmd.2021.02.009_bib0023","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nmd.2011.05.007","article-title":"A study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients","volume":"21","author":"Waddell","year":"2011","journal-title":"Neuromuscul disord"},{"key":"10.1016\/j.nmd.2021.02.009_bib0024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2010.06.017","article-title":"A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations","volume":"296","author":"Chen","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2021.02.009_bib0025","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1212\/WNL.0b013e31823a0ebe","article-title":"Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy","volume":"77","author":"Selcen","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.02.009_bib0026","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/NEN.0b013e3182a23506","article-title":"Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders","volume":"72","author":"Malfatti","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2021.02.009_bib0027","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/mus.23500","article-title":"Novel FHL1 mutation in a family with reducing body myopathy","volume":"47","author":"Schreckenbach","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.02.009_bib0028","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2021.02.009_bib0029","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbagrm.2008.08.001","article-title":"KyoT3, an isoform of murine FHL1, associates with the transcription factor RBP-J and represses the RBP-J-mediated transactivation","volume":"1779","author":"Liang","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nmd.2021.02.009_bib0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1128\/MCB.18.1.644","article-title":"LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein","volume":"18","author":"Taniguchi","year":"1998","journal-title":"Mol Cell Biol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:59Z","timestamp":1760775059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0960896621000377"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.02.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and genetic characteristics of Chinese patients with reducing body myopathy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}